14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 MGNX stock ended at $16.05. This is 1.95% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 4.80% from a day low at $15.62 to a day high of $16.37.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
Sep 13, 2016 $29.09 $29.26 $27.43 $28.42 288 000
Sep 12, 2016 $28.38 $29.62 $27.97 $29.47 443 900
Sep 09, 2016 $29.67 $30.06 $28.55 $28.57 187 300
Sep 08, 2016 $29.88 $30.36 $29.62 $30.07 184 100
Sep 07, 2016 $30.69 $30.75 $29.66 $29.99 202 900
Sep 06, 2016 $29.98 $30.54 $29.57 $29.97 297 600
Sep 02, 2016 $30.26 $30.30 $29.46 $29.64 93 500
Sep 01, 2016 $29.83 $30.35 $29.70 $30.05 215 700
Aug 31, 2016 $29.98 $30.09 $29.21 $29.81 218 400
Aug 30, 2016 $30.00 $30.37 $29.44 $30.03 243 600
Aug 29, 2016 $30.14 $30.54 $29.82 $29.97 196 200
Aug 26, 2016 $29.41 $30.23 $29.41 $30.00 223 600
Aug 25, 2016 $29.35 $30.14 $28.55 $29.26 192 600
Aug 24, 2016 $31.35 $31.99 $29.01 $29.24 239 500
Aug 23, 2016 $31.70 $31.94 $31.35 $31.43 189 900
Aug 22, 2016 $30.90 $31.81 $30.47 $31.80 166 700
Aug 19, 2016 $31.09 $31.20 $30.45 $30.66 159 300
Aug 18, 2016 $30.91 $31.39 $30.71 $31.17 142 900
Aug 17, 2016 $31.51 $31.51 $30.54 $30.90 184 000
Aug 16, 2016 $31.63 $32.25 $31.09 $31.52 242 400
Aug 15, 2016 $31.45 $33.30 $31.45 $31.83 362 200
Aug 12, 2016 $30.95 $31.64 $30.47 $31.29 193 000
Aug 11, 2016 $30.21 $31.41 $29.58 $31.14 213 100
Aug 10, 2016 $30.83 $31.32 $29.72 $29.89 148 400
Aug 09, 2016 $30.78 $31.37 $29.98 $31.33 165 700
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT